The high prevalence of sarcopenia in patients with ovarian and endometrial cancers underscores the importance of early ...
In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...
How common is endometrial cancer? In the United States, cancer of the endometrium (the lining of the uterus) is the most common cancer of the female reproductive organs. The American Cancer Society ...
Expert Rev Anticancer Ther. 2009;9(1):75-96. Based on the available data, FDG-PET alone appears to be of limited use in differentiating tumors of low malignant potential from benign tumors and ...
To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal ...
Compared with chemotherapy alone, the addition of radiation to chemotherapy did not improve overall or recurrence-free survival in patients with locally advanced endometrial cancer, a new phase 3 ...
AI models outperform traditional statistics in predicting post-complete cytoreduction outcomes in ovarian cancer patients. AI's diagnostic accuracy was high for predicting overall survival and no ...
Immunotherapy represents a groundbreaking therapeutic approach, based on the immune system’s intrinsic capacity to interfere with tumor progression, that opens the horizons in the treatment of ...
Endometrial cancer (EC), one of the most common gynecologic malignancies worldwide, poses a significant burden particularly among young women, with poor treatment outcomes and prognosis for advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results